ANXA5 and autoimmune polyendocrinopathy: The “seronegative APS” was recognized as a distinctive setting [22] or was better redefined by the demonstration of new classes of antiphospholipid antibodies directed toward clotting proteins (i.e., prothrombin and annexin-5, acting as phospholipids cofactors).